Transphorm, Inc. Common Stock
TGAN
TGAN was delisted on the 20th of June, 2024.
21 hedge funds and large institutions have $205M invested in Transphorm, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
+$156M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$25.3M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$6.09M |
| 4 |
SFM
Soros Fund Management
New York
|
+$4.74M |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$4.28M |
Top Sellers
TGAN Hedge Fund Activity: Q1 2022 in Review
21 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Transphorm, Inc. Common Stock (TGAN) for Q1 2022, worth a combined $205M.
Buyers outnumbered sellers: 21 funds opened new TGAN positions and 0 closed out — a net gain of 21 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Kohlberg Kravis Roberts & Co, opening a new position worth an estimated $156M.
- 21 institutional investors held Transphorm, Inc. Common Stock (TGAN) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $205M of Transphorm, Inc. Common Stock stock for Q1 2022.
- 21 funds opened new Transphorm, Inc. Common Stock positions in Q1 2022 and 0 closed out, a net change of +21 holders.
- The largest Transphorm, Inc. Common Stock buyer in Q1 2022 was Kohlberg Kravis Roberts & Co, an estimated $156M added.
Based on aggregated 13F filings for Q1 2022.